Support:+1 929 202 3014 info@abvigenus.com

Hapten

Axitinib, BSA

Product Description

  • Type:
  • Hapten
  • Source:
  • synthesis
  • Application:
  • Immunology
  • Description:
  • Format:
  • Liquid
  • Purity:
  • >90%
  • Concentration:
  • Please refer to the vial lable for the specific concentration.
  • Purification:
  • SDS-PAGE
  • Buffer:
  • Supplied in PBS; pH 7.4.
  • Storage:
  • Store at -20 degree for long term.

General Information

  • Background:
  • Axitinib is used for advanced renal cell carcinoma that is ineffective in other systemic treatments. Before starting Inlyta, it is necessary to fully control blood pressure and monitor and treat hypertension. The most common (≥ 20%) adverse reactions are diarrhea, hypertension, fatigue, decreased appetite, and nausea.
  • Synonyms:
  • Axitinib; (E)-N-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide; Inlyta

Documents

Order Details

Cat No:ABSPA-H156

Conjugate:ABSPA-H156

Size:1 mg

Request a quote
Contact us
  • +1 929 202 3014
  • info@abvigenus.com